Merck & Co., Inc., the giant pharmaceutical company, had the following actual data for fiscal year ended December 31, 2011 ($ in millions):
Assets, beginning of period ............ $105,781
Assets, end of period ................ 105,128
Liabilities, beginning of period .......... A
Liabilities, end of period ............. D
Other shareholders’ equity, beginning of period .... 19,269
Other shareholders’ equity, end of period ....... 17,953
Retained earnings, beginning of period ........ 37,536
Retained earnings, end of period ......... C
Total revenues ................ 48,047
Cost of sales and all other expenses ......... 41,775
Net earnings ................... B
Dividends and other decreases in retained earnings ... 4,818
Find the unknowns ($ in millions), showing computations to support your answers.